SCHEDULE: Titan Trust 2024 I Disposes of Entire Stake in DarioHealth Corp.
Beneficial Ownership Disclosure
Titan Trust 2024 I has reported the complete disposition of its beneficial ownership in DarioHealth Corp., reducing its stake to 0% of the common stock.
Summary
- Titan Trust 2024 I, a Delaware statutory trust, has filed an Amendment No. 2 to Schedule 13G, indicating a complete disposition of its beneficial ownership in DarioHealth Corp.
- As of March 31, 2025, Titan Trust 2024 I holds 0 shares of DarioHealth Corp. common stock, representing 0% of the class.
- The disposition occurred during the three months ended March 31, 2025.
- The shares disposed of included 2,499,828 shares acquired on November 14, 2024, through the cashless exercise of a warrant dated February 15, 2024.
- Additionally, 2,499,698 shares acquired on February 18, 2025, through the cashless exercise of a second warrant dated February 15, 2024, were also disposed of.
- The total number of shares disposed of amounts to 4,999,526 shares.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of a change in beneficial ownership, specifically a complete disposition of shares. It does not contain positive or negative operational or financial news for the issuer, thus maintaining a neutral sentiment based solely on the content.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of a change in beneficial ownership by a significant investor and does not provide direct insights into broader industry trends or competitive landscape for DarioHealth Corp. It reflects an investor's portfolio decision rather than an operational update.
Stakeholder Impact
- Shareholders: The complete disposition of a significant stake by an institutional investor could be perceived negatively, potentially signaling a lack of long-term confidence or a rebalancing of the investor's portfolio, which might influence market sentiment and share price.
Key Dates
| Date | Description |
|---|---|
| 2024-02-15 | Date of two warrants exercised by Titan Trust 2024 I. |
| 2024-11-14 | Date of cashless exercise of the first warrant, resulting in 2,499,828 shares issued to Titan Trust 2024 I. |
| 2025-02-18 | Date of cashless exercise of the second warrant, resulting in 2,499,698 shares issued to Titan Trust 2024 I. |
| 2025-03-31 | Date of event which requires filing of this statement, marking the end of the three-month period during which 100% of shares were disposed. |
| 2025-07-18 | Date the Schedule 13G Amendment No. 2 was signed and filed. |
Keywords
DarioHealth Corp., Titan Trust 2024 I, Schedule 13G, beneficial ownership, common stock, share disposition, warrant exercise, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.